Princeton Alpha Management’s United Therapeutics UTHR Stock Holding History

Princeton Alpha Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,089	Closed	-$601K	–	882
2016 Q3	$601K	Buy	+5,089	New	+$611K	0.11%	285
2016 Q2	–	Sell	-1,850	Closed	-$206K	–	978
2016 Q1	$206K	Buy	+1,850	New	+$234K	0.03%	623
2015 Q3	–	Sell	-4,935	Closed	-$858K	–	919
2015 Q2	$858K	Buy	+4,935	New	+$888K	0.17%	177
2014 Q3	–	Sell	-29,013	Closed	-$2.57M	–	835
2014 Q2	$2.57M	Buy	+29,013	New	+$2.79M	0.53%	31

Other funds holding UTHR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Princeton Alpha Management's UTHR Position: Q4 2016 in Review

Princeton Alpha Management sold out of United Therapeutics (UTHR) in Q4 2016, closing a stake of 5,089 shares — an estimated $601K sold.

Princeton Alpha Management first reported a position in UTHR in Q2 2014 and held it in 4 quarters. The position peaked at $2.57M in Q2 2014. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

Princeton Alpha Management reported no remaining United Therapeutics position as of Q4 2016 after selling out during the quarter.
Princeton Alpha Management sold 5,089 United Therapeutics shares in Q4 2016, an estimated $601K.
Princeton Alpha Management first reported a position in United Therapeutics in Q2 2014 and held it in 4 quarters.
Princeton Alpha Management's United Therapeutics position peaked at $2.57M in Q2 2014.
406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on Princeton Alpha Management's 13F filing for Q4 2016, filed 10 Feb 2017.